DHA Gummy
Natural health product licensed in Canada
- Licence holder
- Richwin Toronto Corporation
- NPN or DIN-HM
- 80076529
- Status
- Active licence
- Licence date
- 4 April 2017
- Revision date
- 7 March 2023
- Form
- Bloc
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Engraulidae - en entier Potency : 46.4 milligramme Docosahexaenoic acid | 116 milligramme | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 23.2 milligramme Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 69.6 milligramme Omega-3 Fatty acids | Not specified | Not calculated |
Non-medicinal ingredients
Sucre, Sorbate de potassium, Sorbitol, Gélatine, Feuilles de Camellia Sinensis, Acide DL-malique, Concentré de jus de pommes, Bêta-carotène, Sirop de glucose, Saveur de fruit naturelle, Acide citrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants et Adolescents | minimum: 4 years ; maximum: 12 years | 4 Bloc(s) | 2 Tous les jours |
| Adultes et adolescents | minimum: 13 years | 4 Bloc(s) | 3 days |
Uses authorised in Canada
Source of omega-3 fatty acids for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Helps maintain cardiovascular health. Helps support the development of the brain, eyes and nerves in children up to 2 years of age.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80076529
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging